BioDlink Named “Emerging CDMO of the Year” at the 2026 Asia-Pacific Biopharma Excellence Awards

2026-03-13 - 13:35

BioDlink has been named “Emerging CDMO of the Year” for its innovation in complex biologics and ADC development. The award recognizes its proprietary technology platforms, scalable manufacturing, and a proven quality system with over 100 audits completed. SUZHOU, China, March 13, 2026 /PRNewswire/ — BioDlink, an innovation-driven Contract Development and Manufacturing Organization (CDMO), today announced